I believe we are beyond "non-event" PR's . . . all PR's/news from here on out is newsworthy and hopefully price-appreciation worthy. Yes, the best is yet to come! Univ of Bologna, MD Anderson, Prurisol, Dana Farber/BIDMC results, Prurisol trial . . . I am still waiting for someone to give me the name of a biopharma Cellceutix size with anywhere near the potential. I don't think there is one.